Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable Non-small Cell Lung Cancer (NSCLC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00995761
What this trial is testing

Biweekly Schedule of Docetaxel and Cisplatin in High Risk Patients With Unresectable Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Gyeongsang National University Hospital 48
Testing effectiveness (Phase 2)Study completedNCT03693300
What this trial is testing

Determine Safety of Durvalumab After Sequential Chemo Radiation in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
AstraZeneca 117
Early research (Phase 1)Study completedNCT05954871
What this trial is testing

Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Either Osimertinib in Participants With Unresectable, Locally Advanced, or Metastatic Non-Small Cell Lung Cancer, or With Cetuximab in Participants With Metastatic Colorectal Cancer

Who this might be right for
Colorectal CancerNon-Small Cell Lung Cancer
Genentech, Inc. 10
Early research (Phase 1)Study completedNCT00020007
What this trial is testing

Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery

Who this might be right for
Lung CancerMetastatic Cancer
National Cancer Institute (NCI)
Post-approval studies (Phase 4)Study completedNCT04541706
What this trial is testing

Lorlatinib in ALK Inhibitor Treated Unresectable Advanced/Recurrent ALK-Positive Non Small Cell Lung Cancer Patients in India

Who this might be right for
Advanced Non-Small Cell Lung Cancer
Pfizer 100
Testing effectiveness (Phase 2)Ended earlyNCT04765709
What this trial is testing

Durvalumab and Chemotherapy Induction Followed by Durvalumab and Radiotherapy in Large Volume Stage III NSCLC

Who this might be right for
Non-small Cell Lung Cancer Stage III
Mario Negri Institute for Pharmacological Research 10
Testing effectiveness (Phase 2)Study completedNCT00033553
What this trial is testing

Combination Chemotherapy and Computer-Planned Radiation Therapy in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 69
Large-scale testing (Phase 3)Looking for participantsNCT07217301
What this trial is testing

A Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung Cancer

Who this might be right for
IO-resistant sqNSCLC
Takeda 600
Testing effectiveness (Phase 2)Study completedNCT03743129
What this trial is testing

Anlotinib After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer（ALTER-L029）

Who this might be right for
Non-Small Cell Lung Cancer Stage III
Anhui Shi, MD 90
Early research (Phase 1)Ended earlyNCT03599518
What this trial is testing

DS-1205c With Gefitinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Daiichi Sankyo Co., Ltd. 20
Testing effectiveness (Phase 2)WithdrawnNCT05718297
What this trial is testing

Brigatinib Post Definitive Chemo-radiotherapy in Patients with ALK-fusion Non-small Cell Lung Cancer

Who this might be right for
NSCLC, Stage IIIALK-rearrangement
ETOP IBCSG Partners Foundation
Large-scale testing (Phase 3)Looking for participantsNCT06758401
What this trial is testing

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Who this might be right for
Non-Small Cell Lung CancerCarcinoma, Non-Small-Cell LungCarcinoma, Non-Small-Cell Lung (NSCLC)
Pfizer 714
Testing effectiveness (Phase 2)Study completedNCT00174772
What this trial is testing

Pulmonart: Docetaxel - Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Neoplasms
Sanofi 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07836543
What this trial is testing

Trastuzumab Rezetecan and Adebrelimab, Alone or in Combination, After Chemoradiotherapy for HER2-Altered Unresectable Stage III Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Ming Chen 105
Testing effectiveness (Phase 2)Looking for participantsNCT06709859
What this trial is testing

Afatinib Combined With Chemotherapy as Conversion Therapy in Unresectable EGFR Sensitive Mutation-positive Stage III NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Shandong Public Health Clinical Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT05592626
What this trial is testing

A Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsGenital Neoplasm, FemaleUrogenital Neoplasms+11 more
Marengo Therapeutics, Inc. 366
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06603987
What this trial is testing

Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA

Who this might be right for
Thoracic Solid Malignant Tumor
Stella Pharma Corporation 30
Testing effectiveness (Phase 2)UnknownNCT00466284
What this trial is testing

Phase II Trial of Tarceva in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Grupo Gallego de Cancer de Pulmon 46
Testing effectiveness (Phase 2)WithdrawnNCT03628144
What this trial is testing

Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung CancerNSCLCNon-small Cell Lung Cancer+4 more
H. Lee Moffitt Cancer Center and Research Institute
Testing effectiveness (Phase 2)Looking for participantsNCT05837052
What this trial is testing

A Phase II Trial to Evaluate the Efficiency and Safety of Serplulimab Plus Chemotherapy as Conversion Therapy in NSCLC

Who this might be right for
Unresectable Lung Non-Small Cell Carcinoma
Zhejiang University 49
Next Page